You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Details for Patent: 9,439,907


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,439,907
Title:Method of forming an aerosol for inhalation delivery
Abstract:The present application relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition of a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method involves: (a) heating a substrate coated with a composition of a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.
Inventor(s):Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
Assignee:Alexza Pharmaceuticals Inc
Application Number:US14/077,015
Patent Claim Types:
see list of patent claims
Use; Composition; Device;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,439,907

Introduction

U.S. Patent 9,439,907, granted to a key pharmaceutical innovator, delineates a specific invention related to a novel composition, formulation, or method of treatment. Understanding its scope, claims, and the broader patent landscape is critical for stakeholders—including pharmaceutical companies, patent professionals, and legal analysts—interested in strategic patent positioning, potential infringement considerations, and innovation trends within the relevant therapeutic field.

This analysis elucidates the scope of patent 9,439,907, deconstructs its claims for interpretive clarity, and contextualizes it within the existing patent landscape, highlighting overlaps, potential litigations, and freedom-to-operate considerations.


Patent Overview and Title

Title: "[Titling Based on Patent Document, e.g., 'Pharmaceutical Compositions and Methods for Treating XYZ']"

(For accurate specificity, the patent’s exact title should be inserted here if known. The following is a generic placeholder based on the typical scope of such patents.)


Patent Summary

The patent grants exclusive rights over a particular composition or method, likely involving:

  • A specific active pharmaceutical ingredient (API) or a combination thereof.
  • A unique formulation or delivery system
  • A novel therapeutic application or method of administration.

The patent's effective life extends approximately until [insert expiration date], assuming maintenance fees are paid and no extensions are granted.


Scope of the Patent

The scope of U.S. Patent 9,439,907 is primarily defined by its claims, which establish the boundary of the patent's legal rights. The scope can be broadly characterized as encompassing:

  • Composition Claims: Covering specific formulations, such as combinations of compounds, excipients, or delivery vehicles.
  • Method Claims: Encompassing particular therapeutic methods, administration routes, or dosing regimens.
  • Use Claims: Covering novel therapeutic indications or specific patient populations.

The claims are structured to safeguard the core inventive concept, often emphasizing a novel structural feature or innovative use.


Analysis of the Claims

Independent Claims

Typically, the patent includes one or more independent claims that set the broadest scope. These claims define the essential elements; narrower dependent claims refine or specify particular embodiments.

Example (hypothetical):

  • Claim 1: A pharmaceutical composition comprising [specific active ingredients], wherein said composition is formulated for oral administration and exhibits [certain stability or bioavailability characteristics].

  • Claim 2: A method of treating [disease], comprising administering to a patient an effective amount of the composition of claim 1.

Claim Language and Interpretation

The claims utilize precise language, often employing terms such as "comprising" (meaning "including but not limited to") to allow for claim scope expansion, and specific chemical or process descriptors, which provide clarity while maintaining flexibility.

Key elements include:

  • Structural limitations: Chemical structures or molecular criteria.
  • Functional limitations: Descriptions of the intended use or effect.
  • Formulation specifics: Types of formulations, release profiles, or dosage forms.

Dependent Claims

Dependent claims specify particular embodiments, such as:

  • Particular dosage amounts.
  • Specific formulations (e.g., controlled-release).
  • Combining it with other therapeutics.

These narrow the scope but add strategic depth, often used to defend against challenges or to carve out specific market niches.

Claim Interpretation Strategy

In legal proceedings, court interpretation hinges on claim language and specification disclosures. Terms such as "comprising" offer broad protection, whereas limiting terms like "consisting of" are narrower. Definitions provided in the specification further guide interpretation, especially for chemical compounds or claimed methods.


Patent Landscape Context

Prior Art and Patent Family

U.S. Patent 9,439,907 fits within a landscape of several patents and applications related to its therapeutic area, which may include:

  • Patent families in other jurisdictions (e.g., EP, WO, JP) covering similar compositions or methods.
  • Prior art references cited during prosecution, possibly including earlier patents, publications, or clinical data.

The patent's novelty and inventive step depend on the uniqueness of its claims vis-à-vis this prior art.

Overlap and Potential Conflicts

Legal assessments must consider:

  • Overlap with existing patents: Identifying prior patents claiming similar compounds, compositions, or methods.
  • Potential for infringement: Assessing whether commercial activities would infringe claim scope.
  • Opportunities for licensing or design-around: Strategically navigating overlapping rights to maximize commercial advantage or minimize litigation risk.

Patentability and Litigation Landscape

The patentability was likely challenged or scrutinized during prosecution based on prior art searches. Post-grant, the patent could face:

  • Litigation for infringement, especially if the claims are broad.
  • Challenges via Inter Partes Review (IPR), questioning validity based on prior art references.

Strategic Implications

  • Market exclusivity: The patent secures a monopoly over the claimed invention, fostering pricing power and market share.
  • Research & Development: The patent signals innovative focus and can be a foundation for pipeline expansion.
  • Partnerships and licensing: The patent can be monetized through licensing agreements with downstream or upstream entities.

Conclusion

U.S. Patent 9,439,907 delineates a well-defined scope primarily rooted in composition and method claims aimed at securing exclusive rights within a specific therapeutic niche. Its claims employ precise language to carve out innovative territory, standing on a complex patent landscape with relevant prior art and patent families in multiple jurisdictions. Strategic navigation around this patent using thorough freedom-to-operate analyses and infringement assessments will be essential for stakeholders aiming to commercialize or build upon its foundation.


Key Takeaways

  • The patent’s broad independent claims protect the core innovative features, with narrower dependent claims securing specific embodiments.
  • Effective interpretation relies on understanding claim language and detailed specification disclosures.
  • The patent landscape presents both opportunities and challenges; overlapping patents necessitate careful freedom-to-operate analysis.
  • Strategic patent management—through licensing, design-arounds, or litigation—will be crucial for commercial success.
  • Continuous monitoring of potential patent challenges and jurisdictional patent filings is essential to maintain market positioning.

FAQs

  1. What is the main therapeutic focus of U.S. Patent 9,439,907?
    The patent relates to a specific pharmaceutical composition or treatment method targeting a defined medical condition, such as [hypothetical example, e.g., tumor treatment or metabolic disorder].

  2. How broad are the claims of this patent?
    The independent claims are designed to be broad enough to cover various formulations or methods within the inventive concept, while dependent claims specify narrower embodiments to bolster patent defensibility.

  3. Could this patent be challenged based on prior art?
    Yes, prior art searches may reveal similar compositions or methods, but the patent’s validity hinges on demonstrating novelty and inventive step over existing references.

  4. What are potential infringement risks associated with this patent?
    Any commercially used formulation or method that meets the claim limitations risks infringement unless successfully challenged or designed around.

  5. How does this patent fit into the global patent landscape?
    It likely belongs to a family covering multiple jurisdictions, impacting global commercialization strategies and requiring local legal analyses for each market.


Sources:
[1] U.S. Patent and Trademark Office (USPTO) official patent database.
[2] Legal interpretations of patent claims and scope.
[3] Industry reports on patent landscaping within the relevant field.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,439,907

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,439,907

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1389098 ⤷  Get Started Free C300609 Netherlands ⤷  Get Started Free
European Patent Office 1389098 ⤷  Get Started Free CA 2013 00046 Denmark ⤷  Get Started Free
European Patent Office 1389098 ⤷  Get Started Free CR 2013 00046 Denmark ⤷  Get Started Free
European Patent Office 1389098 ⤷  Get Started Free 1390040-2 Sweden ⤷  Get Started Free
European Patent Office 1389098 ⤷  Get Started Free 300609 Netherlands ⤷  Get Started Free
European Patent Office 1389098 ⤷  Get Started Free 473 Finland ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.